View on Peak SINGLEDosage chartTirzepatide
Dual Agonist (GLP-1/GIP)
LY3437943 · GIP / GLP-1 / glucagon triple agonist
Retatrutide is taken once weekly under the skin. The reference protocol starts at 2 mg and steps up every 4 weeks only if tolerated, to a studied maximum of 12 mg. Mix 1 mL of bacteriostatic water into the 10 mg vial (or 2 mL into the 20 mg vial) for 10 mg/mL — so 2 mg is 20 units on a U-100 syringe.
Reviewed 25 Oct 2026 · Education only, not medical advice
Gradual weekly approach · 10 mg vial + 1 mL BAC water
1 mL in the 10 mg vial or 2 mL in the 20 mg vial both give 10 mg/mL, so 10 units = 1 mg and every step up to 9 mg fits in one syringe. Peak's 10 mg page also shows a 2 mL mix (5 mg/mL) — switch above to see those units.
| Week | Weekly dose | Syringe units | Syringe fill |
|---|---|---|---|
| Weeks 1–4Start | 2 mg | 20 units0.2 mL | |
| Weeks 5–8 | 4 mg | 40 units0.4 mL | |
| Weeks 9–12 | 6 mg | 60 units0.6 mL | |
| Weeks 13–16 | 9 mg | 90 units0.9 mL | |
| Week 17 onwardsMax | 12 mg | 120 units1.2 mL · 2 syringe drawsMore than one 10 mg vial — use the 20 mg vial |
Once weekly · same day each week · subcutaneous injection
Step up only after at least 4 weeks on the current dose, and only if it is well tolerated. If side effects are bothersome, stay on the current step.
4 mg and 9 mg were also studied as ongoing doses — 12 mg is the maximum studied, not a dose everyone needs to reach.
Steps match the escalation used in Eli Lilly's phase 3 TRIUMPH trials. Retatrutide is not an approved medicine in Australia — education only, not medical advice. Dose amounts adapted from Retatrutide 10 mg vial dosage protocol (PeptideDosages.com); units are recalculated for the vial and mix selected above.
Using a 1 mL (100-unit) insulin syringe, one full draw of bacteriostatic water gives 10 mg/mL.
1Wipe both rubber stoppers with an alcohol swab and let them dry. Draw 1 mL of bacteriostatic water and let it run slowly down the inside of the vial wall — not straight onto the powder.
2Swirl or roll the vial gently until the powder has dissolved. Give it a few minutes to settle if needed.
3Shaking can damage the peptide and cause foaming. Gentle swirling only.
4Only use it once it is fully clear with no particles. Label the vial with the date and 10 mg/mL, then store it in the fridge at 2–8 °C.
Counts follow the dosage chart above at the highest amount in each step, using a 10 mg vial mixed with 1 mL.
Plus an approved sharps container. Syringes and swabs are sold by Australian pharmacies — Peak Peptides and Pure Performance supply the bacteriostatic water.
Enter your vial, water and dose to see the matching syringe units.
Concentration
10.00 mg/mL
(10000 mcg/mL)
Calculated Liquid Volume
0.200 mL
Equivalent U-100 volume scale position
Illustration of a U-100 volume scale, not preparation or injection guidance
Retatrutide (LY3437943) is a single molecule that activates three hormone receptors: GIP, GLP-1 and glucagon — which is why it's called a triple agonist.
GLP-1 and GIP signalling reduce appetite and improve blood-sugar control. Glucagon-receptor activity is thought to increase energy use and reduce liver fat.
Guidance: World Health Organization · National Diabetes Services Scheme (NDSS)
It depends on how much water you added. In a 10 mg vial, 2 mg is 40 units with 2 mL of water (5 mg/mL), 20 units with 1 mL (10 mg/mL), and 60 units with 3 mL.
1 mL gives 10 mg/mL (10 units = 1 mg), which keeps every step up to 9 mg inside one 1 mL syringe. Peak's guide also shows 2 mL, which gives 5 mg/mL (20 units = 1 mg). For the 20 mg vial, 2 mL gives 10 mg/mL. Use the selector above the chart to match your mix.
In the trials, no sooner than every 4 weeks — not every week — and only if the current dose is well tolerated.
Five weekly doses at 2 mg, or two and a half doses at 4 mg. Higher steps use more than one 10 mg vial — Peak also lists a 20 mg vial.
View on Peak SINGLEDosage chartDual Agonist (GLP-1/GIP)
View on Peak SINGLEDosage chartCagrilintide (Long-Acting Amylin Analogue)
View on Peak SINGLEDosage chartAnti-Obesity Drug 9604
Cited example and evidence context